Back to top
more

Addus HomeCare (ADUS)

(Delayed Data from NSDQ)

$126.27 USD

126.27
146,545

+1.85 (1.49%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $126.18 -0.09 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 12% (29 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

EVHC vs. ADUS: Which Stock Should Value Investors Buy Now?

EVHC vs. ADUS: Which Stock Is the Better Value Option?

    John Blank headshot

    Is a Summer Swoon On the Way?

    June is historically a flat month for stocks. Any catalysts this time?

      ADUS vs. USPH: Which Stock Is the Better Value Option?

      ADUS vs. USPH: Which Stock Is the Better Value Option?

        John Blank headshot

        No Spending Lift from the Consumer? Zacks June Market Strategy

        Real Personal Consumption expenditures has been strikingly weak in this recovery. A peak of +3.9% in Real PCE happened in Q1-2015. This growth rate has been sliding down ever since.

          What Falling Estimates & Price Mean for Quorum Health (QHC)

          Quorum Health (QHC) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.

            Trina Mukherjee headshot

            4 Value Stocks for Growth Investors to Enrich Portfolio

            On the back of an improving economy, we have zeroed in on four value stocks for growth investors, likely to enrich their portfolio.

              The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum

              The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum

                3 Healthcare Stocks Set to Beat Q1 Earnings Estimates

                Elevated flu activity, aging population, high expenses, and a low tax rate would influence healthcare stocks' earnings in Q1.

                  Envision Healthcare (EVHC) to Report Q1 Earnings: What's Up?

                  Envision Healthcare's (EVHC) Q1 earnings should see an upside from higher revenues at both its segments.

                    The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson

                    The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson

                      Tirthankar Chakraborty headshot

                      Wall Street Brushes Off Trade War Fears: Top 5 Gainers

                      The Dow climbed more than 700 points after investors downplayed fears over tariffs announced by both China and the United States.

                        Is Addus HomeCare (ADUS) Stock a Solid Choice Right Now?

                        Addus HomeCare (ADUS) could be an interesting play for investors as it is seeing solid earnings estimate revision in addition to having a robust industry rank.

                          Addus HomeCare (ADUS) Shares March Higher, Can It Continue?

                          As of late, it has definitely been a great time to be an investor in Addus HomeCare Corporation (ADUS).

                            New Strong Sell Stocks for December 5th

                            Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                              New Strong Sell Stocks for November 16th

                              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                The Zacks Analyst Blog Highlights: Malibu Boats, Addus Homecare, Exelixis, Gran Tierra Energy and Delek Logisitcs Partners

                                The Zacks Analyst Blog Highlights: Malibu Boats, Addus Homecare, Exelixis, Gran Tierra Energy and Delek Logisitcs Partners

                                  DaVita Banks on Acquisitions, Escalating Expenses a Concern

                                  On Jun 23, we issued an updated research report on Denver, CO-based DaVita HealthCare Partners Inc. (DVA).

                                    Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Addus HomeCare, Luminex, Silgan Holdings and Two Harbors Investment

                                    Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Addus HomeCare, Luminex, Silgan Holdings and Two Harbors Investment

                                      Avoid Market Volatility with 5 Low-Beta Stocks

                                      In this article, we present a strategy which proves that low risky securities can also reap rewards if some specific parameters are considered.

                                        Zacks.com featured highlights: Summer Infant, TerraVia Holdings, Addus HomeCare,Schnitzer Steel Industries and Research Frontiers

                                        Zacks.com featured highlights: Summer Infant, TerraVia Holdings, Addus HomeCare,Schnitzer Steel Industries and Research Frontiers

                                          Tirthankar Chakraborty headshot

                                          New Strong Buy Stocks for May 23rd

                                          Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

                                            Use Rising P/E Tactic to Find Out 5 Winning Stocks

                                            Cross the age-old barrier of low P/E investing, bet on these five stocks that boast a rising P/E.

                                              Conatus (CNAT) Q1 Loss Narrows Y/Y, Revenues Beat Estimates

                                              Conatus Pharmaceuticals Inc. (CNAT) reported first-quarter 2017 loss of 14 cents per share, in line with the Zacks Consensus Estimate but narrower than the year-ago figure of 35 cents.

                                                HealthSouth Corp (HLS) Looks Good: Stock Moves 8% Higher

                                                HealthSouth Corporation (HLS) shares rose almost 8% in the last trading session.

                                                  Orexigen Posts Wider-than-Expected Loss in Q4; Sales Up Y/Y

                                                  Orexigen Therapeutics, Inc.???s (OREX) loss of $2.67 per share in the fourth quarter of 2016, significantly wider than the both Zacks Consensus Estimate of a loss of 54 cents and the year-ago loss of $1.20.